FRANKFURT—Wolfgang Glabus, who recently left the senior editorial staff of business magazine Capital, has joined financial communications firm A&B Financial Dynamics, as managing director. Glabus will advise German and international firms on mergers and acquisitions, IPOs, ongoing financial communications and crisis situations related to capital markets. He served as editor of the Frankfurter Allgemeine Zeitung, at business magazine Wirtschaftswoche as head of the companies section, in the same role at Focus Money, and at Cicero as head of the political magazine’s new economy section. Since 2005 he has been a managing member of the chief editorial team of Capital.
LONDON—Aage Dünhaupt has been named director of corporate communications for Europe at Deutsche Lufthansa. Dünhaupt, former been head of international communications at Lufthansa Technik in Hamburg, takes over from Peter Middleton, who left the company last year. He will be responsible for directing and coordinating communi¬cation and media relations for the Lufthansa Group in all European markets except Germany.
LONDON—Cohn & Wolfe has strengthened its corporate affairs leadership with the promotion of Ros Hunt to its board of directors. Hunt will work alongside the existing director, Lee Murgatroyd, to lead the agency’s 20-strong corporate affairs team which works for clients including Diageo, Barclays Wealth and the Learning and Skills Council. She joined Cohn & Wolfe’s corporate affairs division in June 2006 after seven years in the corporate team at Hill & Knowlton.
LONDON—Lisa Rodwell is promoted to director of consumer health and Catherine Hartley to associate director at Virgo Health PR. In addition, Siân Boisseau has joined as a director. Boisseau previously worked at Shire Health London as client services director and client lead on the Nicorette account. At Virgo, she will direct the accounts for Cervarix (GSK’s forthcoming HPV vaccine) and Roche’s Mircera, for the treatment of anemia associated with chronic renal failure. Rodwell joined Virgo in June 2005 and leads the Nurofen account as well as Boehringer Ingelheim’s consumer health portfolio. Hartley joined Virgo earlier this year.